E-Prescribing Market Analysis 2024 -2033: Forecasted Market Size, Top Segments, And Largest Region

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2315

The Business Research Company offers in-depth market insights through E-Prescribing Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The e-prescribing market size has grown exponentially in recent years. It will grow from $2.12 billion in 2023 to $2.65 billion in 2024 at a compound annual growth rate (CAGR) of 25.0%. The growth in the historic period can be attributed to regulatory mandates, medication errors reduction, improved patient safety, enhanced prescription workflow, increased prescriber efficiency.

The e-prescribing market size is expected to see exponential growth in the next few years. It will grow to $6.47 billion in 2028 at a compound annual growth rate (CAGR) of 25.0%. The growth in the forecast period can be attributed to growing telemedicine sector, personalized medicine, prescription drug monitoring programs, medication therapy management, global e-prescribing initiatives. Major trends in the forecast period include interoperability and health information exchange, medication reconciliation, electronic prior authorization, medication adherence tools, erx for controlled substances, ai-driven alerts and decision support.

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=6938&type=smp

Market Segmentation:
The main types of components in e-prescribing are solutions and services. Services refer to the non-physical, intangible parts of our economy, as opposed to goods, which we can touch or handle. The deployment is web-based, cloud-based, and on-premise. The various end-users involved are hospitals, office-based physicians, and pharmaceuticals.

Major Driver - Growing Emphasis On Error Reduction Drives E-Prescribing Market Expansion
The rising focus on reducing medical errors is expected to propel the growth of the e-prescribing market going forward. Medical error refers to an avoidable adverse effect of medical care on a patient. E-prescribing has significantly reduced errors resulting from undecipherable physician handwriting. For instance, in May 2023, according to National Library of Medicine, a US-based medical library, medical errors in hospitals and clinics lead to the deaths of approximately 100,000 people each year. Therefore, the rising focus on reducing medical errors is driving the growth of the e-prescribing market.

Competitive Landscape:
Major companies operating in the e-prescribing market include Epic Systems Corporation, Allscripts Healthcare Solutions Inc., NextGen Healthcare Inc., Athenahealth, Relay Health, Henry Schein Inc., GE Healthcare, Computer Programs and Systems Inc., DrFirst.com Inc., Surescripts, Medical Information Technology, Change Healthcare, Health Fusion Inc., eMDs Inc., iMedX Inc., Cerner Corporation, Practice Fusion Inc., eClinicalWorks LLC, Greenway Health LLC, AdvancedMD Inc., Kareo Inc., PracticeSuite Inc., Advanced Data Systems Corporation, Aprima Medical Software Inc., Compulink Healthcare Solutions, CureMD Healthcare, MacPractice Inc., Medsphere Systems Corporation, Modernizing Medicine Inc., NueMD LLC, Office Ally Inc., Optum Inc., PatientNOW Inc., protected cell company, Sevocity Inc.

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/e-prescribing-global-market-report

Top Trend - Technological Transformation Drives Innovations In The E-Prescribing Market
The advent of technological transformation in healthcare is a key trend gaining popularity in the e-prescribing market. Major companies operating in the e-prescribing market are focused on developing new technological solutions to strengthen their position. For instance, in April 2022, Change Healthcare, a US-based healthcare technology company that includes e-prescribing, launched InterQual 2022, the latest edition of the company's flagship clinical decision support solution for the delivery of the latest and evidence-based appropriate care. This includes new criteria for emergent trends, restructured and interactive criteria to streamline workflows, and artificial intelligence (AI) to drive proactive insights and efficiency. All updates have been researched and independently peer-reviewed, so users will feel confident that the criteria are free of bias.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. E-Prescribing Market Characteristics
3. E-Prescribing Market Trends And Strategies
4. E-Prescribing Market - Macro Economic Scenario
5. E-Prescribing Market Size And Growth
…..
27. E-Prescribing Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.